Correlation Between 4D Molecular and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and Blueprint Medicines Corp, you can compare the effects of market volatilities on 4D Molecular and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and Blueprint Medicines.
Diversification Opportunities for 4D Molecular and Blueprint Medicines
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between FDMT and Blueprint is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of 4D Molecular i.e., 4D Molecular and Blueprint Medicines go up and down completely randomly.
Pair Corralation between 4D Molecular and Blueprint Medicines
Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to under-perform the Blueprint Medicines. In addition to that, 4D Molecular is 1.12 times more volatile than Blueprint Medicines Corp. It trades about -0.14 of its total potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.2 per unit of volatility. If you would invest 8,277 in Blueprint Medicines Corp on August 28, 2024 and sell it today you would earn a total of 1,110 from holding Blueprint Medicines Corp or generate 13.41% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
4D Molecular Therapeutics vs. Blueprint Medicines Corp
Performance |
| Timeline |
| 4D Molecular Therapeutics |
| Blueprint Medicines Corp |
4D Molecular and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 4D Molecular and Blueprint Medicines
The main advantage of trading using opposite 4D Molecular and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| 4D Molecular vs. Eliem Therapeutics | 4D Molecular vs. HCW Biologics | 4D Molecular vs. Scpharmaceuticals | 4D Molecular vs. Milestone Pharmaceuticals |
| Blueprint Medicines vs. Eliem Therapeutics | Blueprint Medicines vs. HCW Biologics | Blueprint Medicines vs. Scpharmaceuticals | Blueprint Medicines vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |